Loading clinical trials...
Loading clinical trials...
Chemoembolisation With Irinotecan Loaded DC Bead (DEBIRI) in Combination With Cetuximab and 5FU/LV in the First Line Treatment of Patients With KRAS Wildtype Metastatic Colorectal Cancer (mCRC)
Conditions
Interventions
DC Bead™
Cetuximab
+2 more
Start Date
September 1, 2012
Primary Completion Date
December 1, 2014
Completion Date
December 1, 2014
Last Updated
December 4, 2014
NCT04704661
NCT06696768
NCT05489211
NCT04657068
NCT06625775
NCT06607458
Lead Sponsor
Universitaire Ziekenhuizen KU Leuven
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions